Get started
Author

Amanda M. Johnson

Observed names: A Johnson, A. Johnson, Amanda Johnson, Amanda M Johnson, Johnson, Amanda M
Institution: Mayo Clinic
ORCID: 0000-0003-2838-0538
Observed ORCID: 0000-0003-2838-0538
OpenAlex ID: A5006201445
The Real-World Effectiveness and Safety of Ustekinumab in the Treatment of Crohn's Disease: Results From the SUCCESS Consortium
2022 · Amanda M. Johnson, Maria Barsky, et al. · The American Journal of Gastroenterology · 70
Obesity in inflammatory bowel disease
2021 · Amanda M. Johnson, Edward V. Loftus · Saudi Journal of Gastroenterology · 51
Prevalence and Impact of Obesity on Disease-specific Outcomes in a Population-based Cohort of Patients with Ulcerative Colitis
2021 · Amanda M Johnson, W Scott Harmsen, et al. · Journal of Crohn s and Colitis · 37
Impact of Obesity on the Management of Inflammatory Bowel Disease.
2020 · Amanda M Johnson, Edward V Loftus · PubMed · 32
Real-World Effectiveness and Safety of Upadacitinib in Crohn’s Disease: A Multicenter Study
2025 · Jalpa Devi, Anthony Xu, et al. · Clinical Gastroenterology and Hepatology · 21
A multicenter study of the real-world effectiveness and safety of risankizumab in Crohn’s disease
2025 · Amanda M Johnson, Manar Askar, et al. · Journal of Crohn s and Colitis · 18
Reviewing the impact of obesity on inflammatory bowel disease and considerations for optimizing management
2024 · Wissam Ghusn, Edward V. Loftus, et al. · Current Opinion in Gastroenterology · 16
Prevalence and Impact of Obesity in a Population-Based Cohort of Patients With Crohn’s Disease
2022 · Amanda M. Johnson, William Scott Harmsen, et al. · Journal of Clinical Gastroenterology · 14
PDF
Quality of bowel preparation for colonoscopy in patients on glucagon-like peptide-1 receptor agonists
2024 · Khushboo Gala, June Tome, et al. · Gastrointestinal Endoscopy · 13
Vulvar Crohn's Disease: Clinical Features and Outcomes
2021 · Janice M. Cho, Edward V. Loftus, et al. · The American Journal of Gastroenterology · 13
Real-World Effectiveness of Ustekinumab in Ulcerative Colitis in a United States Multicenter Cohort Consortium
2024 · Andres J Yarur, Ryan Ungaro, et al. · Inflammatory Bowel Diseases · 12
PDF
Risankizumab to treat moderately to severely active Crohn’s disease in adults: an evaluation of trials and data
2023 · Amanda M. Johnson, Edward V. Loftus · Expert Review of Gastroenterology & Hepatology · 11
Effectiveness and Safety of Antiobesity Medications in Patients With Obesity and Inflammatory Bowel Disease
2023 · Jonathan T. Pham, Wissam Ghusn, et al. · The American Journal of Gastroenterology · 10
Research Priorities to Support Women Veterans’ Reproductive Health and Health Care Within a Learning Health Care System
2023 · Jodie G. Katon, Adriana Rodriguez, et al. · Women s Health Issues · 10
PDF
An evaluation of risankizumab for the treatment of moderate-to-severe ulcerative colitis
2024 · Amanda M. Johnson, Edward V. Loftus · Expert Opinion on Biological Therapy · 5
Endoscopic Bariatric Therapies for the Management of Obesity in Patients with Inflammatory Bowel Disease
2022 · Amanda M. Johnson, Andrew C. Storm, et al. · Obesity Surgery · 4
Real-World Effectiveness of Upadacitinib for Perianal Crohn’s Disease: A Multicenter Retrospective Study
2026 · Jalpa Devi, Anish Patel, et al. · Clinical Gastroenterology and Hepatology · 3
Tu1882 REAL-WORLD EFFECTIVENESS AND SAFETY OF UPADACITINIB IN CROHN'S DISEASE: A MULTICENTER STUDY
2024 · Jalpa Devi, Navreet M. Chowla, et al. · Gastroenterology · 3
611 the Real-world Effectiveness of Ustekinumab in the Treatment of Crohn's Disease
2021 · Amanda M. Johnson, Maria Barsky, et al. · Gastroenterology · 3
P325 Real-World Effectiveness And Safety Of Ustekinumab In Patients With Ulcerative Colitis: A Multi-Centre Study
2021 · D Parakkal, A Johnson, et al. · Journal of Crohn s and Colitis · 3
Certolizumab Trough Levels and Antibodies in Crohn Disease: A Single-Center Experience
2021 · Guilherme Piovezani Ramos, Badr Al-Bawardy, et al. · Crohn s & Colitis 360 · 3
Key Mechanisms by Which Post-ICU Activities Can Improve In-ICU Care - Results of the International Thrive Collaboratives
2019 · K.J. Haines, C.M. Sevin, et al. · 3
The intersection of trauma, mental health, and reproductive health among women veterans: A scoping review
2025 · Yael I. Nillni, Anna C. Barbano, et al. · Clinical Psychology Review · 2
Performance of Google NotebookLM for AI-assisted data extraction and consensus statement generation in a heterogenous systematic review on inflammatory bowel disease, obesity, and cardiometabolic comorbidities: A Methodological Report
2026 · Sami Samaan, Jalpa Devi, et al. · medRxiv · 1
PDF
Modulate Obesity and relateD metabolic complIcations For Yielding improvements in IBD outcomes (MODIFY-IBD): Consensus on Obesity and Cardiometabolic Comorbidities in Inflammatory Bowel Disease using Evidence Synthesis and the RAND/UCLA Appropriateness Method
2025 · Jalpa Devi, Sami Samaan, et al. · medRxiv · 1
Works count: 74
Citation count: 366
H-index: 11
I10-index: 14
Year
Topic
Type